Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 853 Records) |
| Query Trace: Hepatitis A and HCC[original query] |
|---|
| RECK gene polymorphisms in hepatitis B-related hepatocellular carcinoma: A case-control study. Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 2022 Aug 23 (3): 201-205. Said Ebada M, Salem Abdelhamed A, Shousha Hend I, Ahmad Enas S, Alazzouny Mahmoud A, Ahmed Inas A, Elfeky Hala M, Abdelsalam Fatma |
| Association of Vitamin D Gene Polymorphisms With HCV Infection Outcome. British journal of biomedical science 2022 79 10237. Neamatallah M, Serria M S, El-Bendary M, El-Gilany A-H, Alhawarey A, Abed S, Setate Y A, Ammar O |
| Inactivation of tumor suppressor TAp63 by hepatitis B virus X protein in hepatocellular carcinoma. Chinese medical journal 2022 8 135 (14): 1728-1733. Xie Bangxiang, Hao Qian, Zhou Xiang, Chen De |
| Genetic dominance of transforming growth factor-?1 polymorphisms in chronic liver disease. Frontiers in immunology 2022 12 13 1058532. Cai Xuanyan, Zha Huiyan, Yang Zhaoxu, Du Yiwen, Dai Xiaoyang, Yang Bo, Wang Jiajia, He Qiaojun, Weng Qinj |
| Genetic Variation of SAMM50 Is Not an Independent Risk Factor for Alcoholic Hepatocellular Carcinoma in Caucasian Patients. International journal of molecular sciences 2022 12 23 (23): . Nischalke Hans Dieter, Schmalz Franziska, Buch Stephan, Fischer Janett, Möller Christine, Matz-Soja Madlen, Krämer Benjamin, Langhans Bettina, Klüners Alexandra, Soyka Michael, Stickel Felix, Nattermann Jacob, Berg Thomas, Strassburg Christian P, Lutz Phili |
| Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B. Cancers 2022 12 14 (23): . Yu Ming-Whei, Lin Chih-Lin, Liu Chun-Jen, Wu Wan-Jung, Hu Jui-Ting, Huang Yi-W |
| The role of PRDM1 gene polymorphism in the progression of hepatocellular carcinoma in Egyptian patients. Journal of medical virology 2022 11 95 (1): e28343. Mohamed Amal Ahmed, Esmail Omnia Ezzat, Ibrahim Aya Mohamed Ahmed, Makled Sahar, Al-Hussain Eman, Elsaid Ali, Alboraie Mohamed, El-Awady Rehab |
| Overview and clinical significance of multiple mutations in individual genes in hepatocellular carcinoma. BMC cancer 2022 Oct 22 (1): 1046. Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Ito Takaaki, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Otsuka Shimpei, Ohnami Sumiko, Nagashima Takeshi, Hatakeyama Keiichi, Sugino Takashi, Urakami Kenichi, Akiyama Yasuto, Yamaguchi K |
| Associations between Extracellular Matrix Protein 1 Gene Polymorphism and Progression of Liver Disease. Genetics research 2022 10 2022 9304264. He Xiuting, Liu Ting, Zhang Rui, Li |
| Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients. Tumour virus research 2022 Oct 14 200249. Hassan Marwa, Attia Mohammed Saad, Ali-Eldin Zainab, El Attar Gamal, Elzallat Mohamed, Saad Hany Haroun Kaisar, Isaac Ami |
| A functional variant in the RAD51 3' UTR is associated with survival of hepatocellular carcinoma patients. Gene 2022 Oct 146964. Qiu Moqin, Liu Yingchun, Lin Qiuling, Jiang Yanji, Zhou Zihan, Wen Qiuping, Liang Xiumei, Zhou Xianguo, Yu Hongpi |
| miR-516a-3P, a potential circulating biomarker in hepatocellular carcinoma, correlated with rs738409 polymorphism in PNPLA3. Personalized medicine 2022 10 19 (6): 483-493. Youssef Samar Samir, Youness Rana Ahmed, Abbas Eman Abd El-Razek, Osman Noha Mohamed, ELFiky Asmaa, El-Kassas Moham |
| TBX5 Variants are Associated with Susceptibility to and the Incidence of Liver Cirrhosis and Hepatocellular Carcinoma in the Chinese Population: A Multicenter and Follow-Up Study. Infection and drug resistance 2023 5 16 2653-2665. JinJian Yao, Xiaochun Mao, Qigang Sun, Biao Wu, Weiling Yu, Yanjing Huang, Shuai Luo, Jia Zeng, Jusheng L |
| Preliminary radiogenomic study of hepatitis B virus-related hepatocellular carcinoma: associations between MRI features and mutations. Personalized medicine 2023 5 . Shanshan Gao, Feihang Wang, Wei Sun, Xianling Qian, Yuan Ji, Yunfeng Cheng, Xiaolin Wang, Lingxiao Liu, Ruofan Sheng, Mengsu Ze |
| Association of DRB1*11 and DRB1*12 alleles of the HLA system with the evolution of the Hepatitis B virus infection in Burkina Faso. Molecular biology reports 2023 4 . Sidnooma Véronique Zongo, Florencia Wendkuuni Djigma, Albert Théophane Yonli, Pegdwendé Abel Sorgho, Bolni Marius Nagalo, Lassina Traore, Dogfounianalo Somda, Lanyo Jospin Amegnona, Eugène Languie, Couna Christiane Bere Some, Lydie Marie Jeannette Sia, Issa Boaffi Sourabie, Roger Arsène Sombie, Abdel Karim Serme, Dorcas Obiri-Yeboah, Jacques Simpo |
| A lipid metabolism-based prognostic risk model for HBV-related hepatocellular carcinoma. Lipids in health and disease 2023 4 22 (1): 46. Zhou Lili, Xia Shaohuai, Liu Yaoyao, Ji Qiang, Li Lifeng, Gao Xuan, Guo Xiaodi, Yi Xin, Chen Fe |
| Pre-S1 Mutations as Indicated by Serum Pre-S1 Antigen Negative is Associated with an Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients. Journal of hepatocellular carcinoma 2023 4 10 599-609. Xingxin Zhang, Chenjian Gu, Qian Wei, Yirong Cao, Weimin She, Hong Shi, Youhua Xie, Jinsheng G |
| Genetic profile of MIF single nucleotide polymorphism (rs755622 G>C) in hepatocellular carcinoma among Egyptian patients. Clinical and experimental hepatology 2023 4 9 (1): 46-56. Osman Heba Ahmed, El-Sayed Marwa, Tag-Adeen Mohammed, Sabra Ahlam, El-Sawy Samer A, Mahmoud Marwa Ahmed, Elwahab Saeda Mohamed Abd, Wahman Mohammed, Hassan Mohammed |
| Antioxidants-related nuclear factor erythroid 2-related factor 2 gene variants associated with HBV-related liver disease. Cancer cell international 2023 4 23 (1): 72. Liu Yanqiong, Wu Qiulian, Zhang Fuyong, Qin X |
| Polymorphisms within DIO2 and GADD45A genes increase the risk of liver disease progression in chronic hepatitis b carriers. Scientific reports 2023 4 13 (1): 6124. Rybicka Magda, Verrier Eloi R, Baumert Thomas F, Bielawski Krzysztof Pio |
| Comprehensive investigating of MMR gene in hepatocellular carcinoma with chronic hepatitis B virus infection in Han Chinese population. Frontiers in oncology 2023 4 13 1124459. Ma Ning, Jin Ao, Sun Yitong, Jin Yiyao, Sun Yucheng, Xiao Qian, Sha XuanYi, Yu Fengxue, Yang Lei, Liu Wenxuan, Gao Xia, Zhang Xiaolin, Li |
| Association of PNPLA3 SNP With the Development of HBV-related Hepatocellular Carcinoma. In vivo (Athens, Greece) 2023 3 37 (2): 763-770. Enomoto Hirayuki, Aizawa Nobuhiro, Ikeda Naoto, Takashima Tomoyuki, Yuri Yukihisa, Okamoto Mamiko, Yoshioka Ryota, Kawata Shoki, Yoshihara Kohei, Ota Shogo, Nakano Ryota, Shiomi Hideyuki, Nishimura Takashi, Iijima Hiro |
| Rs9679162 genotype predicts prognosis of real-world advanced hepatocellular carcinoma treated by sorafenib. Cancer biomarkers : section A of Disease markers 2023 3 . Lin Chih-Lang, Chien Rong-Nan, Chen Li-Wei, Chu Yu-De, Yeh Chau-Ti |
| High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy. Journal of gastroenterology 2023 3 . Chang Xiujuan, Li Yinying, Sun Chao, Li Xiaodong, Du Wenjuan, Shang Qinghua, Song Laicheng, Long Qinghua, Li Qin, Liu Huabao, Wang Jing, Yu Zujiang, Li Jiang, Xiao Guangming, Li Li, Chen Liang, Tan Lin, Chen Yongping, Yang Yongpi |
| Prediction Model with HLA-A*33:03 Reveals Number of Days to Develop Liver Cancer from Blood Test. International journal of molecular sciences 2023 3 24 (5): . Nishida Nao, Ohashi Jun, Suda Goki, Chiyoda Takehiro, Tamaki Nobuharu, Tomiyama Takahiro, Ogasawara Sachiko, Sugiyama Masaya, Kawai Yosuke, Khor Seik-Soon, Nagasaki Masao, Fujimoto Akihiro, Tsuchiura Takayo, Ishikawa Miyuki, Matsuda Koichi, Yano Hirohisa, Yoshizumi Tomoharu, Izumi Namiki, Hasegawa Kiyoshi, Sakamoto Naoya, Mizokami Masashi, Tokunaga Katsus |
| Polymorphism Analysis of Interleukin-18 and Interleukin-37 Genes in Hepatitis B Infections with Different Outcomes: A Preliminary Report from an Iranian Population. Asian Pacific journal of cancer prevention : APJCP 2023 2 24 (2): 411-416. Molaei Vahid, Fattahi Mohammad Reza, Haghshenas Mohammad Reza, Hosseini Seyed Younes, Malekhosseini Seyed Ali, Sarvari Jam |
| Comprehensive investigating of mismatch repair genes (MMR) polymorphisms in participants with chronic hepatitis B virus infection. Frontiers in genetics 2023 2 14 1077297. Ma Ning, Sun Yucheng, Kong Yanan, Jin Yiyao, Yu Fengxue, Liu Lianfeng, Yang Lei, Liu Wenxuan, Gao Xia, Liu Dianwu, Zhang Xiaolin, Li |
| Elucidating the role of missense SNP of protein kinase C epsilon in HCV-induced hepatocellular carcinoma. BMC cancer 2023 2 23 (1): 147. Rehman Areeba, Shabbir Maria, Badshah Yasmin, Khan Khushbukhat, Trembley Janeen H, Ashraf Naeem Mahmood, Afsar Tayyaba, Almajwal Ali, Alruwaili Nawaf W, Alshamari Ali, Alanezi Tariq Nahar, Razak Suha |
| Tolloid-like 1 gene variant rs17047200, pretreatment FIB-4, ALBI and PALBI scores as predictors of hepatocellular carcinoma occurrence after directly acting antivirals. Clinical and experimental hepatology 2023 1 8 (4): 330-334. Kamal Ahmed, Mohsin Ali Kareem, Matta Cecil, Ghazy Ramy Mohamed, Elhadidi Abeer, Tahoun Mona, Rahal Amr, Domiaty Donia, Mohamed Ne |
| Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis B. Pathogens (Basel, Switzerland) 2023 1 12 (1): . Fischer Janett, Long Shuang, Koukoulioti Eleni, Müller Tobias, Fueloep Balazs, Heyne Renate, Eslam Mohammed, George Jacob, Finkelmeier Fabian, Waidmann Oliver, Berg Thomas, van Bömmel Flori |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: